News > Serum Institute gets approval for Phase 2, 3 trials

Serum Institute gets approval for Phase 2, 3 trials

India’s apex drug regulatory body has granted approvals to Serum Institute of India to conduct late-stage human trials for the Oxford Covid-19 vaccine candidate in India.

Now that the chief of the Central Drugs Standard Control Organisation has signed off on the proposal, as confirmed by the health ministry Monday, SII will be able to kick-off the trials here, effectively putting it ahead in India’s own race for a Covid-19 vaccine.